RCE in Duraspace Vitro
CVE-2019-6986
SPARQL Injection in VIVO Vitro v1.10.0 allows a remote attacker to execute arbitrary SPARQL via the uri parameter, leading to a regular expression denial of service (ReDoS), as demonstrated by crafted use of FILTER%20regex in a /individual?uri= request.
Vulnerability class: Command Injection (OS Command Injection)
Published · last modified .
CVSS v3 metric
CVSS v3 base score 7.5 (High). Vector: CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H.
EPSS exploit prediction
EPSS: 0.030 (86.9th percentile), scored .
Low probability of exploitation in the next 30 days, but still tracked. 87th percentile — 86.9% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.030 · newest: 0.030 · change: 0.000
Affected products
- Duraspace Vitro — versions 1.10.0
Weakness classification (CWE)
Public proof-of-concept exploits
References
- github.com/kevinbackhouse/SecurityExploits/tree/0ec74459ac53685a7959ed58d580ef8… (Exploit, Third Party Advisory)
- github.com/vivo-project/Vitro/pull/111 (Patch, Third Party Advisory)
- packetstormsecurity.com/files/172838/VIVO-SPARQL-Injection.html
Frequently asked questions
- What is CVE-2019-6986?
- CVE-2019-6986 is a high-severity vulnerability in Duraspace Vitro, classified under Command Injection. CVSS score: 7.5/10. Published 2019-01-28.
- How severe is CVE-2019-6986?
- High severity. CVSS v3 base score is 7.5 out of 10.
- Is CVE-2019-6986 known to be exploited?
- 1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.